We are live on ! Find out more
MAA

Managed Account Advisors Portfolio holdings

AUM $121B
1-Year Est. Return 7.32%
This Fund
S&P 500
This Quarter Est. Return
+5.07%
1 Year Est. Return
+7.32%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$101B
AUM Growth
+$11.3B
Cap. Flow
+$7.67B
Cap. Flow %
7.59%
Top 10 Hldgs %
9.07%
Holding
2,867
New
173
Increased
1,129
Reduced
1,339
Closed
119

Top Sells

Rank Stock Value
1
KMR
KINDER MORGAN MANAGEMENT LLC
KMR
+$305M
2
GILD icon
Gilead Sciences
GILD
+$142M
3
HAL icon
Halliburton
HAL
+$107M
4
GSK icon
GSK
GSK
+$81.3M
5
MSFT icon
Microsoft
MSFT
+$81.1M

Sector Composition

Rank Sector Weight
1 Financials 12.47%
2 Healthcare 12.04%
3 Technology 11.57%
4 Industrials 9.75%
5 Consumer Discretionary 8.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACHN
2601
DELISTED
Achillion Pharmaceuticals
ACHN
$2K ﹤0.01%
+190
New +$2.32K
VWR
2602
DELISTED
VWR Corporation
VWR
$2K ﹤0.01%
+69
New +$1.65K
KITE
2603
DELISTED
Kite Pharma, Inc.
KITE
$2K ﹤0.01%
+42
New +$1.77K
DYAX
2604
DELISTED
DYAX CORPORATION
DYAX
$2K ﹤0.01%
+124
New +$1.55K
DBA icon
2605
Invesco DB Agriculture Fund
DBA
$1.23B
$1K ﹤0.01%
28
HYI
2606
Western Asset High Yield Opportunity Fund Inc
HYI
$133M
$1K ﹤0.01%
+46
New +$747
PEO
2607
Adams Natural Resources Fund
PEO
$733M
$1K ﹤0.01%
+29
New +$720
XES icon
2608
State Street SPDR S&P Oil & Gas Equipment & Services ETF
XES
$370M
$1K ﹤0.01%
4
+3
+300% +$981
XLRN
2609
DELISTED
Acceleron Pharma
XLRN
$1K ﹤0.01%
+28
New +$976
LCM
2610
DELISTED
Advent/Claymore Enhanced Gth & F
LCM
$1K ﹤0.01%
+57
New +$523
ARIA
2611
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$1K ﹤0.01%
+211
New +$1.32K
LINE
2612
DELISTED
LINN ENERGY LLC COM UTS REP LTD LIABILITY CO INTS
LINE
$1K ﹤0.01%
+61
New +$1.25K
LMNS
2613
DELISTED
LUMENIS LTD CL B ORD SHS (ISR)
LMNS
$1K ﹤0.01%
118
AOL
2614
DELISTED
AOL INC COMMON STOCK
AOL
$1K ﹤0.01%
15
-57,393
-100% -$2.53M
FM
2615
DELISTED
iShares Frontier and Select EM ETF
FM
$1K ﹤0.01%
+44
New +$1.53K
UBC
2616
DELISTED
E-TRACS UBS Bloomberg CMCI Livestock ETN
UBC
$1K ﹤0.01%
25
DWSN
2617
DELISTED
DAWSON GEOPHYSICAL CO
DWSN
$1K ﹤0.01%
+100
New +$1.49K
ABG icon
2618
Asbury Automotive
ABG
$4.22B
-18,582
Closed -$1.2M
ABUS icon
2619
Arbutus Biopharma
ABUS
$871M
$0 ﹤0.01%
+9
New +$155
AIVL icon
2620
WisdomTree US AI Enhanced Value Fund
AIVL
$428M
$0 ﹤0.01%
+6
New +$449
ALLT icon
2621
Allot
ALLT
$373M
-103,602
Closed -$1.18M
ANDE icon
2622
Andersons Inc
ANDE
$2.54B
-21,395
Closed -$1.34M
ARES icon
2623
Ares Management
ARES
$28.8B
-114,653
Closed -$2.01M
ARR
2624
Armour Residential REIT
ARR
$2.01B
0
AWF
2625
AllianceBernstein Global High Income Fund
AWF
$868M
$0 ﹤0.01%
+1
New +$13

Similar funds

Managed Account Advisors's Q4 2014 Portfolio in Review

As of Q4 2014, Managed Account Advisors held 2,867 positions worth $101B, up 13% from $89.7B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.

Managed Account Advisors deployed $7.67B of net new capital in Q4 2014, opening 173 new positions and adding to 1,129 existing holdings. Its largest new stake was Schwab US Dividend Equity ETF: 9,780,387 shares worth $130M.

By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Gilead Sciences, an estimated $142M trimmed.

  • Managed Account Advisors's largest Q4 2014 buy was Schwab US Dividend Equity ETF: 9,780,387 shares worth $130M.
  • Managed Account Advisors added most to iShares Russell 1000 Growth ETF in Q4 2014, an estimated $467M increase.
  • Managed Account Advisors's biggest Q4 2014 reduction was Gilead Sciences, cutting an estimated $142M.
  • Managed Account Advisors fully exited KINDER MORGAN MANAGEMENT LLC in Q4 2014, selling an estimated $305M.
  • Managed Account Advisors's ten largest holdings make up 9.1% of its $101B portfolio in Q4 2014.
  • Managed Account Advisors opened 173 new positions and closed 119 in Q4 2014.
  • Managed Account Advisors's portfolio value rose 13% quarter-over-quarter to $101B.

Based on Managed Account Advisors's 13F filing for Q4 2014, filed 13 Feb 2015.